Skip to main content
Clinical Trials/NCT04831853
NCT04831853UnknownNot Applicable

Comparison for Sensitivity and Tolerance of Self-swabbing and Conventional Nasopharyngeal Swabbing for SARS-CoV-2 Detection for Pain, Discomfort and Acceptability: a Randomized Controlled Non-inferiority Study

University Hospital, Clermont-Ferrand1 site in 1 country400 target enrollmentStarted: April 1, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
400
Locations
1
Primary Endpoint
Non-inferiority of self-swabbing compared to conventional swabbing concerning diagnosis sensitivity

Study Overview

Brief Summary

Self-swabbing requires less personal protective equipment and could allow to test more people and even to do quick self-diagnosis if antigenic tests are available.

In a preliminary study on 190 medical students, the investigators have shown that self and conventional swabbing were identically well-accepted with equivalent level of pain and discomfort induced by swabbing. In a sub-group of this sample, the investigators have shown that the quality of the 2 sampling methods were equivalent.

The goal of this large study in the general population is to confirm these findings in an adequately powered study. Such results would allow to develop self-swabbing for large screening campaigns and eventually self-diagnosis using antigenic tests.

Detailed Description

All consecutive subjects coming to the 2 dedicated centers for COVID-19 screening in Clermont-Ferrand University hospital (one for medical students and one for the general population) will be asked to be included in the present study. They will be randomly assigned to either supervised self-swabbing followed by conventional swabbing led by a healthcare professional or the other way round.

All the subjects will have to complete a brief questionnaire including demographical characteristics (age, sex, height, weight, eye color), potential symptoms (asthenia, fever, anosmia...) anticipated pain and discomfort and previous nasopharyngeal swabbing experience. Pain, discomfort and overall acceptability of the procedure will be completed just after completion of the swabbing.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Any subject coming for nasopharyngeal swabbing for SARS-CoV-2 screening
  • •Fluent in French (both oral and written)
  • •Able to give an eclaired consent

Exclusion Criteria

  • •Contra-indication to nasopharyngeal swabbing
  • •Refusal to participate
  • •Pregnant women

Arms & Interventions

Supervised self-swabbing followed by conventional swabbing

Experimental

the subjects will first benefit from a 5 minutes explanation on how to perform self-swabbing and will then performed the swabbing under the supervision of a trained healthcare professional

Intervention: nasopharyngeal swabbing procedure (self swabbing first) (Other)

Conventional swabbing followed by supervised self-swabbing

Experimental

the subject will undergo conventional nasopharyngeal swabbing performed by a trained healthcare professional first.

Intervention: nasopharyngeal swabbing procedure (conventionnal swabbing first) (Other)

Outcomes

Primary Outcomes

Non-inferiority of self-swabbing compared to conventional swabbing concerning diagnosis sensitivity

Time Frame: 5 minutes after the end of the procedure of nasopharyngeal swabbing

assessed using consistency of COVID-19 RT-PCR results for both sampling modalities (Self- swabbing versus conventional-swabbing). If non-inferiority is confirmed on this criterion, pain will be tested.

Secondary Outcomes

  • Non-inferiority of self-swabbing compared to conventional swabbing concerning acceptability(5 minutes after the end of the procedure of nasopharyngeal swabbing)
  • Correlation between body mass index and swabbing-induced pain(5 minutes after the end of the procedure)
  • Non-inferiority of self-swabbing compared to conventional swabbing concerning pain(5 minutes after the end of the procedure of nasopharyngeal swabbing)
  • Correlation between symptoms (fever, headache, asthenia, anosmia, agueusia, cough, dyspnea, muscle pain, sore throat, diarrhea) and swabbing-induced pain(5 minutes after the end of the procedure)
  • Correlation between anticipated pain and actual pain(5 minutes after the end of the procedure)
  • Correlation between anticipated discomfort and actual discomfort.(5 minutes after the end of the procedure)
  • Correlation between age, sex and swabbing-induced pain(5 minutes after the end of the procedure)
  • Correlation between eye color and swabbing-induced pain(5 minutes after the end of the procedure)
  • Correlation between eye color and swabbing-induced discomfort(5 minutes after the end of the procedure)
  • Richness assessment for respiratory cells(Day 0)
  • Non-inferiority of self-swabbing compared to conventional swabbing concerning pain discomfort(5 minutes after the end of the procedure of nasopharyngeal swabbing)

Investigators

Sponsor
University Hospital, Clermont-Ferrand
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials